1. Home
  2. FVRR vs CMPX Comparison

FVRR vs CMPX Comparison

Compare FVRR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$11.03

Market Cap

372.4M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
CMPX
Founded
2010
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.4M
408.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FVRR
CMPX
Price
$11.03
$2.10
Analyst Decision
Buy
Strong Buy
Analyst Count
9
9
Target Price
$18.43
$14.57
AVG Volume (30 Days)
706.2K
3.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
$934.41
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.58
$1.61
52 Week High
$28.00
$6.88

Technical Indicators

Market Signals
Indicator
FVRR
CMPX
Relative Strength Index (RSI) 51.55 43.19
Support Level $9.93 $1.88
Resistance Level $11.43 $2.14
Average True Range (ATR) 0.46 0.11
MACD 0.03 -0.01
Stochastic Oscillator 40.65 21.43

Price Performance

Historical Comparison
FVRR
CMPX

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: